You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secondary progressive MS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

Withdrawn
  • Primary Progressive Multiple Sclerosis
  • +2 more
  • Intranasal Foralumab Solution
  • Placebo
  • (no location specified)
Feb 14, 2022

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Metformin Hydrochloride 850 mg Oral Tablet
    • Placebo
    • Brugge, Belgium
    • +4 more
    May 30, 2023

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2021

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Imaging Interplay Between Axonal Damage and Repair in Multiple

      Recruiting
      • Multiple Sclerosis (MS)
      • +3 more
      • MRI
      • +2 more
      • Basel, Switzerland
        University Hospital Basel, Department of Neurology
      Dec 15, 2021

      MS - a Prospective Cohort Study

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • PASS-MS
      • Berlin, Germany
        Experimental and Clinical Research Center, Studienambulanz Neuro
      Aug 9, 2021

      Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

      Completed
      Has Results
      • Secondary Progressive Multiple Sclerosis
      • Primary Progressive Multiple Sclerosis
      • Dublin, Dublin 4, Ireland
      • +1 more
      Jul 8, 2021

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

      Active, not recruiting
      • Primary Progressive Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • ATA188
      • Placebo
      • La Jolla, California
      • +33 more
      Jul 21, 2022

      MSRV-Env Burden in Patients With Multiple Sclerosis Disease

      Completed
      • Multiple Sclerosis (MS)
      • +4 more
      • No study treatments administered - blood draws only
      • Bron cedex, France
      • +3 more
      Oct 19, 2020

      Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

      Recruiting
      • Relapsing Multiple Sclerosis
      • +2 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • Best Available Therapy (BAT)
      • Palo Alto, California
      • +20 more
      Jan 25, 2023

      Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

      Recruiting
      • Secondary-progressive Multiple Sclerosis
      • Buffalo, New York
        University at Buffalo, Buffalo General Hospital
      Oct 10, 2022

      Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

      Completed
      • Multiple Sclerosis (MS)
      • +6 more
      • Video-oculography / Social cognition tasks / Neuropsychological evaluations
      • Monaco, Monaco
        Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
      Jan 19, 2021

      Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

      Recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Ferumoxytol infusion
      • +2 more
      • Salt Lake City, Utah
        University of Utah Health Imaging and Neurosciences Center
      Jun 22, 2022

      Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

      Not yet recruiting
      • Multiple Sclerosis
      • (no location specified)
      Nov 15, 2023

      Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))

      Completed
      Has Results
      • Multiple Sclerosis, Chronic Progressive
      • NurOwn (MSC-NTF cells)
      • Los Angeles, California
      • +3 more
      Oct 20, 2022

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

      Recruiting
      • Progressive Multiple Sclerosis
      • Placebo
      • Masitinib (4.5)
      • Lille, France
      • +1 more
      Jul 1, 2022

      Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

      Recruiting
      • Relapsing Remitting Multiple Sclerosis
      • +2 more
      • Glostrup, Copenhagen, Denmark
      • +11 more
      May 3, 2022

      Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

      Completed
      • Secondary Progressive Multiple Sclerosis
        • Camperdown, New South Wales, Australia
        • +1 more
        Apr 19, 2023

        Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

        Not yet recruiting
        • Multiple Sclerosis (MS)
        • +6 more
        • Clemastine Fumarate
        • Placebo
        • San Francisco, California
          Sandler Neurosciences Building, Neurological Clinical Research U
        Jan 23, 2023

        Progressive Multiple Sclerosis, Fatigue Trial in San Francisco (N-acetyl cysteine, Placebo)

        Completed
        Has Results
        • Progressive Multiple Sclerosis
        • Fatigue
        • N-acetyl cysteine
        • Placebo
        • San Francisco, California
          University of California San Francisco
        Sep 6, 2022